BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Mise à jour : Il y a 4 ans
Référence : NCT01672671

Femme Homme

Extrait

The purpose of this study is to assess efficacy of platinum-based neoadjuvant chemotherapy in correlation with BRCA1-associated DNA repair dysfunction in patients with early triple negative breast cancer.


Critère d'inclusion

  • Early Triple Negative Breast Cancer

Liens